Researchers identify four new target molecules for future personalized MS treatment

Currently available therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects.

Related Keywords

Stockholm ,Sweden ,Swedish ,Karolinska Institutet ,Guro Gafvelin ,Olab Nilsson ,Claudia Carvalho Queiroz ,Tomas Olsson ,Andreas Kaiser ,Emily Henderson ,Mattias Bronge ,Roland Martin ,Department Of Clinical Neuroscience ,Swedish Research Council ,Swedish Brain Fund ,Uggla Foundation ,Royal Institute Of Technology ,Science Advances ,Clinical Neuroscience ,Professor Tomas Olsson ,Professor Roland Martin ,Human Protein Atlas ,Professor Torbj ,Co Authors Claudia Carvalho Queiroz ,Brain ,Fell ,Central Nervous System ,Hronic ,Inflammatory Disease ,Multiple Sclerosis ,Nervous System ,Eurons ,Research ,Clerosis ,Herapeutics ,Walking ,